Tina’s Wish Presents Inaugural Global Women’s Health Award to President Bill Clinton
New York, NY (PRWEB) April 16, 2015 -- Tina’s Wish, the only nonprofit organization dedicated exclusively to funding research for the early detection of ovarian cancer, honored President Bill Clinton with the inaugural Tina’s Wish Global Women’s Health Award at a reception at the Waldorf Astoria New York on April 14th. Hundreds attended the event which raised much-needed funds that will benefit Tina’s Wish and its mission to find an effective way to diagnose ovarian cancer at its earliest, most curable stage.
“If there is one solid rule that is true all around the world, it is that creative networks of cooperation are the best way to solve problems faster, cheaper and better,” said President Clinton during his acceptance speech. “The global impact of ovarian cancer is so great because of the absence of early detection. By being here tonight, you are playing a small role in a giant collaborative effort to guarantee a 100% survival rate from this disease, redeeming Tina’s wish and the best parts of the unfulfilled lives of every person we’ve ever lost.”
The Tina’s Wish Global Women’s Health Award was created to honor individuals whose contributions to the betterment of women’s health have been extraordinary. President Clinton was chosen as the first recipient because of the lasting impact the Clinton Foundation’s work is having on women’s health globally. Both Tina’s Wish and the Clinton Foundation were founded on the principle that turning an idea into action is best achieved through collaboration.
“It was an inspirational evening and we thank President Clinton for joining us and sharing his thoughts on how working together to solve problems can make the biggest impact,” said Andrew Brozman, Tina’s husband and member of the Tina’s Wish board of directors. “We are grateful to those who came out to support this important cause and we are already looking forward to next year’s ceremony.”
President Clinton was presented the award by The Honorable Cecelia Morris, Chief Justice of the U.S. Bankruptcy Court for the Southern District of New York and member of the Tina’s Wish board of directors.
Since its inception, Tina’s Wish has become the third largest private funding source dedicated to ovarian cancer research and established The Tina Brozman Ovarian Cancer Research Consortium which is comprised of five world-class research institutions. In 2014, The Foundation established one of the first ever consortium grants to benefit ovarian cancer, The Rita M. Kirpalani Memorial Consortium Grant for Ovarian Cancer Research. Through this grant, six research teams will work together on the same set of specimens with the goal of finding an early detection screen.
Ovarian cancer is often misdiagnosed or identified in advanced stages due to lack of symptoms and no available tests for early detection. On average, 61% of ovarian cancer patients are diagnosed in advanced stages of the disease when the 5-year survival rate is only 27%. In contrast, those diagnosed in Stage I/II have a 5-year survival rate of 92%. The collaborative work of the Tina’s Wish research teams in the U.S. has the potential to make a global impact on the number of women who die each year from the disease.
Tina's Wish honors the memory of Tina Brozman, former chief judge of the U.S. Bankruptcy Court for the Southern District of New York, who died at the age of 54 following a two-year battle with ovarian cancer. The organization will host its next event, the Tina’s Wish Women’s Committee Spring Reception, on Monday, May 18, at the Time Warner Center in New York City.
For more information, please visit tinaswish.org, “like” Tina's Wish on Facebook and follow them on Twitter.
About Tina's Wish
Officially known as The Honorable Tina Brozman Foundation for Ovarian Cancer Research, “Tina's Wish,” is a Section 501(c)(3) charitable organization and the only organization dedicated exclusively to funding groundbreaking research for the early detection and prevention of ovarian cancer. Tina's Wish maintains that the most effective way to fight ovarian cancer is to diagnose it at its earliest, most curable stage. Since 2008, the Foundation has raised millions of dollars to fund grants and created a collaborative research consortium, bringing together scientists from five world-class institutions that are developing innovative prevention and diagnostic strategies.
Lisa Santacruz, Co-Communications, Inc., +1 9146660066, [email protected]
Share this article